In this study, Rusakiewicz et al. identified a new mechanism for NK involvement in SS where dysfunctional regulation by NK cells via NCR3/Nkp30 permits over activation of DCs, facilitating activation of lymphocytes and systemic immunity [82]. The gene discussed is NCR3; the disease is synovial sarcoma.